tiprankstipranks
Theranexus SA (DE:3VG)
FRANKFURT:3VG
Holding DE:3VG?
Track your performance easily

Theranexus SA (3VG) Income Statement

0 Followers

Theranexus SA Income Statement

Last quarter (Q2 2022), Theranexus SA's total revenue was €―, a decrease of ― from the same quarter last year. In Q2, Theranexus SA's net income was €―. See Theranexus SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
-€ 0.00€ 0.00€ 0.00€ 0.00-
Cost of Revenue
-€ 5.55M€ 3.57M€ 5.43M€ 4.97M€ 1.48M
Gross Profit
-€ -5.55M€ -3.57M€ -5.43M€ -4.97M-
Operating Expense
-€ 3.96M€ 2.53M€ 1.95M€ 2.02M€ 1.24M
Operating Income
-€ -9.51M€ -6.10M€ -7.38M€ -6.99M€ -2.72M
Net Non Operating Interest Income Expense
-€ -360.54K€ 186.55K€ -254.12K€ -31.30K€ -124.80K
Other Income Expense
------
Pretax Income
-€ -9.91M€ -5.79M€ -7.62M€ -7.02M€ -2.85M
Tax Provision
-€ -1.76M€ -993.73K€ -2.04M€ -1.72M€ -730.33K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-€ -8.15M€ -4.80M€ -5.58M€ -5.30M€ -2.11M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
-€ 9.51M€ 6.10M€ 7.38M€ 6.99M€ 2.72M
Net Income From Continuing And Discontinued Operation
-€ -8.15M€ -4.80M€ -5.58M€ -5.30M€ -2.11M
Normalized Income
-€ -8.15M€ -4.92M€ -5.58M€ -5.30M€ -2.11M
Interest Expense
-€ 33.20K€ 110.36K€ 102.93K€ 56.45K€ 128.66K
EBIT
-€ -9.88M€ -5.68M€ -7.52M€ -6.97M€ -2.72M
EBITDA
-€ -8.67M€ -5.30M€ -7.36M€ -6.91M€ -2.69M
Currency in EUR

Theranexus SA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis